Decentralised clinical trials and sites: friend or foe?
While the notion of sites disappearing from clinical trials is not a threat anymore, sponsors need to ensure appropriate support to avoid technological burdens.
Positive topline data for Bolt’s BDC-1001 in HER2 solid tumours
Nanoscope’s gene therapy nabs Phase II win in retinitis pigmentosa
Vaccitech’s chronic Hepatitis B drug sees positive topline data
Intra-Cellular reports positive Phase III trial of Caplyta in MDD and bipolar depression
Revive enrols first patient into psilocybin trial for substance use disorder
Analysis
View More
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
Themes
View MoreInvivyd begins subject dosing in Covid-19 mAb candidate trial
The trial will assess the pharmacokinetics, tolerability, and safety of VYD222 monoclonal antibody candidate for Covid-19.
More themes
Insights
View MoreWho’s hiring who? Hiring activity related to social responsibility increased by 10% in the pharmaceutical industry in Q3 2022
The global pharmaceutical industry experienced a 10% rise in new job postings related to social responsibility in Q3 2022 compared…
MediMergent uses digital clinical trials platform in cancer trial
YS Biopharma reports positive data from Covid-19 vaccine trial
Syneos Health and KX partner for data-driven insights
Cloudbyz launches new electronic data capture platform for clinical trials